ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Advanced Biomed Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$4.16+0.18 (+4.52%)
Close on Oct 19, 2026
- Market cap
- $6.51M
- P/E (TTM)
- 0.8
- Dividend yield
- –
Ownership
Who owns Advanced Biomed's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Pau Hung To | 176,225 | 12.75% | 13G (passive) | Oct 24, 2022 |
| Lee Chen Yi | 123,840 | 7.50% | 13G (passive) | Mar 6, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Hung To Pau | 10% owner | 0 | – | Aug 20, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Hung To Pau 10% owner | Jul 27, 2026 | Other | −76,225 | $480000.00 | $36.59B | 0 |
| Hung To Pau 10% owner | Jul 27, 2026 | Other | −100,000 | $480000.00 | $48.00B | 76,225 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.